Oncogenic transformation in the absence of Xrcc4 targets peripheral B cells that have undergone editing and switching
Open Access
- 8 December 2008
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 205 (13) , 3079-3090
- https://doi.org/10.1084/jem.20082271
Abstract
Nonhomologous end-joining (NHEJ) repairs DNA double-strand breaks (DSBs) during V(D)J recombination in developing lymphocytes and during immunoglobulin (Ig) heavy chain (IgH) class switch recombination (CSR) in peripheral B lymphocytes. We now show that CD21-cre–mediated deletion of the Xrcc4 NHEJ gene in p53-deficient peripheral B cells leads to recurrent surface Ig-negative B lymphomas (“CXP lymphomas”). Remarkably, CXP lymphomas arise from peripheral B cells that had attempted both receptor editing (secondary V[D]J recombination of Igκ and Igλ light chain genes) and IgH CSR subsequent to Xrcc4 deletion. Correspondingly, CXP tumors frequently harbored a CSR-based reciprocal chromosomal translocation that fused IgH to c-myc, as well as large chromosomal deletions or translocations involving Igκ or Igλ, with the latter fusing Igλ to oncogenes or to IgH. Our findings reveal peripheral B cells that have undergone both editing and CSR and show them to be common progenitors of CXP tumors. Our studies also reveal developmental stage-specific mechanisms of c-myc activation via IgH locus translocations. Thus, Xrcc4/p53-deficient pro–B lymphomas routinely activate c-myc by gene amplification, whereas Xrcc4/p53-deficient peripheral B cell lymphomas routinely ectopically activate a single c-myc copy.Keywords
This publication has 64 references indexed in Scilit:
- 53BP1 facilitates long-range DNA end-joining during V(D)J recombinationNature, 2008
- Rearrangement of Mouse Immunoglobulin Kappa Deleting Element Recombining Sequence Promotes Immune Tolerance and Lambda B Cell ProductionImmunity, 2008
- AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangementsThe Journal of Experimental Medicine, 2007
- Regulation of AID expression in the immune responseThe Journal of Experimental Medicine, 2007
- Receptor editing in lymphocyte development and central toleranceNature Reviews Immunology, 2006
- Evasion of the p53 tumour surveillance network by tumour-derived MYC mutantsNature, 2005
- The role of the non‐homologous end‐joining pathway in lymphocyte developmentImmunological Reviews, 2004
- Requirement for an Interaction of XRCC4 with DNA Ligase IV for Wild-type V(D)J Recombination and DNA Double-strand Break Repairin VivoJournal of Biological Chemistry, 1998
- Neoteny in Lymphocytes: Rag1 and Rag2 Expression in Germinal Center B CellsScience, 1996
- Reexpression of RAG-1 and RAG-2 Genes in Activated Mature Mouse B cellsScience, 1996